QS316. Enhanced in Vitro and in Vivo Anti-Tumor Activity of Bortezomib (Velcade®, PS-341) When Administered With Interferon-Alpha
Year: 2008
Type: conference-abstract
Source: Journal of Surgical Research
Institution: The Ohio State University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1992250691
